(VIANEWS) – RYANAIR HOLD. PLC (RYA.IR), BW LPG (BWLPG.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 28.95% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, and internationally. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services, as well as in-flight sale of beverages, food, duty-free, and merchandise; and markets car hire, travel insurance, and accommodation services through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. Ryanair Holdings plc was incorporated in 1996 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.16.
PE Ratio
RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 13.89. Meaning, the purchaser of the share is investing €13.89 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.95%.
Sales Growth
RYANAIR HOLD. PLC’s sales growth for the next quarter is 38.7%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 150% and a drop 144.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 40.3%, now sitting on 11.82B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RYANAIR HOLD. PLC’s EBITDA is 316.68.
More news about RYANAIR HOLD. PLC.
2. BW LPG (BWLPG.OL)
31.1% sales growth and 20.16% return on equity
BW LPG Limited, an investment holding company, engages in shipowning and chartering activities worldwide. The company operates through Shipping and Product Services segments. It is involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. The company also offers integrated liquified petroleum gas (LPG) delivery services directly to buyers and receivers. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr27.48.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 5.02. Meaning, the purchaser of the share is investing kr5.02 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 26, 2023, the estimated forward annual dividend rate is 39.9 and the estimated forward annual dividend yield is 33.62%.
Sales Growth
BW LPG’s sales growth is 20.3% for the ongoing quarter and 31.1% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BW LPG’s EBITDA is 79.74.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 114% and 6%, respectively.
More news about BW LPG.
3. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.2. Meaning, the purchaser of the share is investing kr32.2 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr38.00 at 12:20 EST, way below its 52-week high of kr43.60 and way higher than its 52-week low of kr29.80.
Volume
Today’s last reported volume for NAVAMEDIC is 5450 which is 85.76% below its average volume of 38279.
More news about NAVAMEDIC.
4. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.09.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 18.51. Meaning, the purchaser of the share is investing kr18.51 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
More news about BOUVET.
5. MOWI (MOWI.OL)
9.7% sales growth and 10.75% return on equity
Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, MOWI has a trailing twelve months EPS of kr8.4.
PE Ratio
MOWI has a trailing twelve months price to earnings ratio of 22.96. Meaning, the purchaser of the share is investing kr22.96 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.75%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.5%, now sitting on 5.34B for the twelve trailing months.
Moving Average
MOWI’s worth is above its 50-day moving average of kr184.40 and above its 200-day moving average of kr180.80.
Yearly Top and Bottom Value
MOWI’s stock is valued at kr192.90 at 12:20 EST, below its 52-week high of kr205.80 and way above its 52-week low of kr130.15.
Volume
Today’s last reported volume for MOWI is 168319 which is 76.65% below its average volume of 721063.
More news about MOWI.
6. ASML HOLDING (ASML.AS)
6.5% sales growth and 68.44% return on equity
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Earnings Per Share
As for profitability, ASML HOLDING has a trailing twelve months EPS of €18.76.
PE Ratio
ASML HOLDING has a trailing twelve months price to earnings ratio of 29.68. Meaning, the purchaser of the share is investing €29.68 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.44%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 1, 2023, the estimated forward annual dividend rate is 5.88 and the estimated forward annual dividend yield is 1.07%.
Volume
Today’s last reported volume for ASML HOLDING is 166040 which is 70.6% below its average volume of 564821.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 7.7% and 5.9%, respectively.
More news about ASML HOLDING.
